Google News

Nasus Pharma (NYSE: NSRX) sets $50M share shelf for working capital and drug development - Stock Titan

Sep 1, 2026, 8:55 PM

Translate article text

Choose a language and wait for the translated text.

Nasus Pharma (NYSE: NSRX) sets $50M share shelf for working capital and drug development  Stock Titan